BACKGROUND: Intra myocardial hemorrhage lesions (IMH) are underdiagnosed complication of ST elevation myocardial infarction (STEMI). We sought to determine the incidence, predictors and the prognostic value of IMH in STEMI using cardiac MR imaging (CMR) techniques. METHODS: We screened for inclusion consecutive patients with STEMI treated by percutaneous coronary intervention (PCI) within the first 12 hr of evolution. IMH lesions were identified on T2-weighted sequences on CMR between days 4 and 8 after PCI. Adverse cardiac events were defined as a composite of death + severe ventricular arrhythmias + acute coronary syndrome + acute heart failure. RESULTS: N = 114 patients were included and n = 11 patients (10%) presented IMH lesions. Patients with IMH lesions had a larger myocardial infarction extent (25.6 ± 1.8 vs. 13.5 ± 1.0 % LV mass, P < 0.01), microvascular obstructive lesions extent (4.6 ± 1.0 vs. 1.3 ± 0.3% LV mass, P < 0.01) and lower LV ejection fraction (40.7 ± 2.3% vs. 50.7 ± 1.3%, P < 0.01). The value of glycemia at admission was an independent predictor of IMH development (Odd ratio 1.8 [1.1-2.8] per mmol l(-1), P = 0.01). The incidence of adverse cardiac events was higher in the IMH group than in the non-IMH group during the first year following STEMI (P = 0.01, log-rank analysis). Cox regression analysis identified the presence of IMH lesions as an independent predictor of adverse clinical outcome (Hazard Ratio = 2.8 [1.2-6.8], P = 0.02). CONCLUSION: Our study indicates that IMH is a rare but severe finding in STEMI, associated with a larger myocardial infarction and a worse clinical outcome. Per-PCI glycemia might influence IMH development.
BACKGROUND:Intra myocardial hemorrhage lesions (IMH) are underdiagnosed complication of ST elevation myocardial infarction (STEMI). We sought to determine the incidence, predictors and the prognostic value of IMH in STEMI using cardiac MR imaging (CMR) techniques. METHODS: We screened for inclusion consecutive patients with STEMI treated by percutaneous coronary intervention (PCI) within the first 12 hr of evolution. IMH lesions were identified on T2-weighted sequences on CMR between days 4 and 8 after PCI. Adverse cardiac events were defined as a composite of death + severe ventricular arrhythmias + acute coronary syndrome + acute heart failure. RESULTS: N = 114 patients were included and n = 11 patients (10%) presented IMH lesions. Patients with IMH lesions had a larger myocardial infarction extent (25.6 ± 1.8 vs. 13.5 ± 1.0 % LV mass, P < 0.01), microvascular obstructive lesions extent (4.6 ± 1.0 vs. 1.3 ± 0.3% LV mass, P < 0.01) and lower LV ejection fraction (40.7 ± 2.3% vs. 50.7 ± 1.3%, P < 0.01). The value of glycemia at admission was an independent predictor of IMH development (Odd ratio 1.8 [1.1-2.8] per mmol l(-1), P = 0.01). The incidence of adverse cardiac events was higher in the IMH group than in the non-IMH group during the first year following STEMI (P = 0.01, log-rank analysis). Cox regression analysis identified the presence of IMH lesions as an independent predictor of adverse clinical outcome (Hazard Ratio = 2.8 [1.2-6.8], P = 0.02). CONCLUSION: Our study indicates that IMH is a rare but severe finding in STEMI, associated with a larger myocardial infarction and a worse clinical outcome. Per-PCI glycemia might influence IMH development.
Authors: Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen Journal: Nat Rev Cardiol Date: 2014-11-18 Impact factor: 32.419
Authors: Brianna F Moon; Srikant Kamesh Iyer; Eileen Hwuang; Michael P Solomon; Anya T Hall; Rishabh Kumar; Nicholas J Josselyn; Elizabeth M Higbee-Dempsey; Andrew Tsourkas; Akito Imai; Keitaro Okamoto; Yoshiaki Saito; James J Pilla; Joseph H Gorman; Robert C Gorman; Cory Tschabrunn; Samuel J Keeney; Estibaliz Castillero; Giovanni Ferrari; Steffen Jockusch; Felix W Wehrli; Haochang Shou; Victor A Ferrari; Yuchi Han; Avanti Gulhane; Harold Litt; William Matthai; Walter R Witschey Journal: Nat Commun Date: 2020-06-29 Impact factor: 14.919
Authors: David Carrick; Caroline Haig; Nadeem Ahmed; Samuli Rauhalammi; Guillaume Clerfond; Jaclyn Carberry; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Stuart Hood; Stuart Watkins; M Mitchell Lindsay; Ahmed Mahrous; Paul Welsh; Naveed Sattar; Ian Ford; Keith G Oldroyd; Aleksandra Radjenovic; Colin Berry Journal: J Am Heart Assoc Date: 2016-02-23 Impact factor: 5.501
Authors: Nilesh R Ghugre; Mihaela Pop; Reuben Thomas; Susan Newbigging; Xiuling Qi; Jennifer Barry; Bradley H Strauss; Graham A Wright Journal: J Cardiovasc Magn Reson Date: 2017-07-04 Impact factor: 5.364
Authors: Jaclyn Carberry; David Carrick; Caroline Haig; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Stuart Hood; Stuart Watkins; Mitchell Lindsay; Andrew Davie; Ahmed Mahrous; Ian Ford; Naveed Sattar; Paul Welsh; Aleksandra Radjenovic; Keith G Oldroyd; Colin Berry Journal: JACC Cardiovasc Imaging Date: 2017-11-15